trin2755
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01259518)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetCROSS-LINKING AGENT
cross-linking agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trin2755
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01259518 | Phase 1 | Nov 1, 2009 | Assign Clinical Research GmbH, Central European Society for Anticancer Drug Research (CESAR), Trin Therapeutics GmbH, University of Duisburg-Essen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assign Clinical Research GmbH | For profit | 1 | 0 | 1 | 2009 |
| Central European Society for Anticancer Drug Research (CESAR) | Government | 1 | 0 | 1 | 2009 |
| Trin Therapeutics GmbH | For profit | 1 | 1 | 1 | 2009 |
| University of Duisburg-Essen | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1